Skip to main content

As the situation in Ukraine evolves, businesses should be mindful of potential risks to their people, assets, operations, or supply chains in the region and globally. Marsh, as part of the Marsh McLennan family of companies, has created a page with information, tools, and resources related to the Russia-Ukraine conflict. Please visit the page for the latest information.

January 25, 2024

Florida agency receives FDA authorization to import prescription drugs from Canada


On January 5, 2024, the U.S. Food and Drug Administration (FDA) authorized Florida’s Agency for Health Care Administration’s drug importation program, allowing Florida to move forward with its plan to import certain drugs from Canada for certain state-run programs. This Alert addresses the FDA’s limited drug importation program, the scope of Florida’s authorization, and potential roadblocks to the successful implementation of the program.

This Alert is most relevant to employers employing Florida residents.